Episode Details

Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashse guidance. So are the disappointing results a sign the weight loss drug boom is slimming out?

Fast Money Disclaimer